Professional Documents
Culture Documents
ORIGINAL ARTICLE
a
Medicinal Chemistry Division, Department of Chemistry, National Institute of Technology-Karnataka, Surathkal,
Mangalore 575 025, India
b
Department of Microbiology, Veterinary College, Hebbal, KVAFSU, Bangalore, India
c
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451,
Kingdom of Saudi Arabia
KEYWORDS Abstract In the present study a series of new Schiff bases were synthesized. All the synthesized
Schiff bases; compounds were characterized by IR, 1H NMR, mass spectral and elemental analyses. Newly syn-
Triazoles; thesized compounds were screened for their antibacterial (Staphylococcus aureus, Bacillus subtilis,
Pyrazoles; Escherichia coli and Pseudomonas aeruginosa) activity. The results revealed that, compounds 3f
Antimicrobial activity and 3c have exhibited significant biological activity against the tested microorganisms.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
et al., 2003; Wu et al., 2007). The pharmacological importance 1H-pyrazole-4-carbaldehyde 2a–e (0.001 mol) was refluxed in
of heterocycles derived from 1,2,4-triazole paved the way to- ethanol-dioxane mixture for 7 h in the presence of a catalytic
wards active research in a triazole chemistry. Pyrazoles repre- amount of concentrated sulfuric acid. The resulting solution
sent a key motif in heterocyclic chemistry and occupy a prime was cooled to room temperature and the precipitated solid
place in medicinal and pesticide chemistry due to their capability was filtered under suction, washed with ethanol and recrystal-
to exhibit a wide range of bioactivities, such as antimicrobial lised from ethanol-dioxane mixture.
(Sultivan et al., 2007; Gilbert et al., 2006; Prakash et al., 2009;
Isloor et al., 2009), anticancer (Magedov et al., 2007), anti- 2.3. Characterization of synthesized compounds
inflammatory (Szabo et al., 2008; Benaamane et al., 2008),
antidepressant (Prasad et al., 2005), anticonvulsant (Ozdemir 2.3.1. 5-Ethyl-4-{[(E)-(3-phenyl-1H-pyrazol-4-yl)methyli-
et al., 2007), antipyretic (Sener et al., 2002), selective enzyme dene]amino}-4H-1,2,4-triazole-3-thiol 3a
inhibitory activities (Wachter et al., 1996) etc. Amongst a large Yield 79%, m.p. 217–219 C. IR (cm 1): 3094 (N–H), 3035
array of medicinally important pyrazole derivatives, 4-function- (Ar–H), 2916 (C–H), 1584 (C‚N). 1H NMR (DMSO-d6)
alized pyrazoles occupy a unique position and their evaluation d = 13.67 (br s, 2H, SH&NH), 9.76 (s, 1H, N‚CH), 8.23 (s,
as antimicrobial agents has attracted much attention in the past 1H, pyrazole-5H), 7.5–7.75 (m, 5H, Ar–H), 2.69 (q, 2H, –
(Prakash et al., 2009; Sridhar et al., 2004; Bekhit et al., 2003; CH2), 1.21 (t, 3H, –CH3). MS [EI] m/z 299 [M+1]. Elemental
Bekhit et al., 2008; Vijesh et al., 2010). Pyrazoles with various analysis (C14H14N6S); calcd. C, 56.36; H, 4.73; N, 28.17; found
functional groups at position-4, such as cyano or oxime (Prak- C, 56.29; H, 4.68; N, 28.11%.
ash et al., 2009), aldehyde or carboxylate (Sridhar et al., 2004)
have been known to show good antimicrobial properties. In 2.3.2. 5-Ethyl-4-({(E)-[3-(4-methoxyphenyl)-1H-pyrazol-4-
view of these and in continuation of our research on biologically yl]methylidene}amino)-4H-1,2,4-triazole-3-thiol 3b
active molecules, we hereby report the synthesis of some new Yield 65%, m.p. 227–229 C. IR (cm 1): 3103 (N–H), 3013
Schiff bases bearing triazole and pyrazole moieties and their (Ar–H), 2929 (C–H), 1603 (C‚N), 1169 (C–O). 1H NMR
antibacterial studies. (DMSO-d6) d = 13.66 (br s, 2H, SH&NH), 9.68 (s, 1H,
N‚CH), 8.26 (s, 1H, pyrazole-5H), 7.67 (d, 2H, J = 8.4 Hz,
2. Experimental Ar–H), 7.0 (d, 2H, J = 8.4 Hz, Ar–H), 3.82 (s, 3H, –OCH3),
2.67 (q, 2H, –CH2), 1.21 (t, 3H, –CH3). MS [EI] m/z 329
2.1. Measurements [M+1]. Elemental analysis (C15H16N6OS); calcd. C, 54.86; H,
4.91; N, 25.59; found C, 54.81; H, 4.88; N, 25.53%.
Melting points were determined by open capillary method and
are uncorrected. The IR spectra (in KBr pellets) were recorded 2.3.3. 5-Ethyl-4-({(E)-[3-(4-fluorophenyl)-1H-pyrazol-4-
on a Thermo Nicolet avatar 330-FT-IR spectrophotometer. 1H yl]methylidene}amino)-4H-1,2,4-triazole-3-thiol 3c
NMR spectra were recorded (DMSO-d6) on a Bruker Yield 63%, m.p. 242–244 C. IR (cm 1): 3109 (N–H), 3054
(400 MHz) spectrometer using TMS as internal standard. (Ar–H), 2877 (C–H), 1599 (C‚N), 1157 (C–F). 1H NMR
Chemical shift values are given in d scales. The mass spectra (DMSO-d6) d = 13.68 (br s, 2H, SH&NH), 9.72 (s, 1H,
were recorded on LC–MS-Agilent 1100 series and API 2000 N‚CH), 8.4 (s, 1H, pyrazole-5H), 7.35–7.80 (m, 4H, Ar–H),
LC/MS system. Elemental analyses were performed on a Flash 2.65 (q, 2H, –CH2), 1.19 (t, 3H, –CH3). MS [EI] m/z 317
EA 1112 series CHNS-O analyser. The completion of the [M+1]. Elemental analysis (C14H13FN6S); calcd. C, 53.15;
reaction was checked by thin layer chromatography (TLC) H, 4.14; N, 26.57; found C, 53.11; H, 4.09; N, 26.52%.
on silica gel coated aluminium sheets (silica gel 60 F254). Com-
mercial grade solvents and reagents were used without further 2.3.4. 4-({(E)-[3-(4-Chlorophenyl)-1H-pyrazol-4-yl]methyli-
purification. The reaction pathway has been summarized in dene}amino)-5-ethyl-4H-1,2,4-triazole-3-thiol 3d
Scheme 1. Yield 67%, m.p. 248–250 C. IR (cm 1): 3129 (N–H), 3078
(Ar–H), 2911 (C–H), 1597 (C‚N), 831 (C–Cl). 1H NMR
2.2. Synthesis (DMSO-d6) d = 13.69 (br s, 2H, SH&NH), 9.76 (s, 1H,
N‚CH), 8.57 (s, 1H, pyrazole-5H), 7.75 (d, 2H, J = 8.4 Hz,
2.2.1. Synthesis of 4-amino-5-substituted-4H-1,2,4-triazole-3- Ar–H), 7.57 (d, 2H, J = 8.4 Hz, Ar–H), 2.65 (q, 2H, –CH2),
thiol 1a–c 1.19 (t, 3H, –CH3). MS [EI] m/z 333 [M+1]. Elemental analy-
The compounds were synthesized according to previously re- sis (C14H13ClN6S); calcd. C, 50.52; H, 3.94; N, 25.25; found C,
ported procedure (Isloor et al., 2009). 50.47; H, 3.88; N, 25.19%.
indicate that, most of the synthesized compounds have shown exhibited excellent activity against S. aureus as compared to
good to moderate activity against S. aureus, B. subtilis, E. coli standard drug Ceftriaxone, whereas similar activity as that of
and P. aeruginosa microorganisms. In particular, compound 3f standard against remaining three microorganisms. Also com-
has exhibited excellent activity against S. aureus whereas it has pound 3c was active at same concentration as that of the stan-
shown activity equal to that of standard drug Ceftriaxone dard in case of all four microorganisms.
against B. subtilis, E. coli and P. aeruginosa microorganisms.
In the case of compound 3c the activity was found to be equal
Acknowledgements
to that of standard drug Ceftriaxone for all four microorgan-
isms. Remaining compounds exhibited similar or moderate
The Authors extend their appreciation to The Deanship of Sci-
antibacterial activity than compared to standard.
entific Research at King Saud University for the funding the
work through the research group project No. RGP-VPP-207.
4. Conclusions
References
In the present work, a series of new pyrazole based Schiff bases
were synthesized and characterized by spectral studies. All the Bekhit, A.A., Ashour, H.M.A., Abdel-Chany, Y.S., Bekhit, A.E.A.,
synthesized compounds were evaluated for their antibacterial Baraka, A., 2008. Eur. J. Med. Chem. 43, 456–463.
activities against S. aureus, B. subtilis, E. coli and P. aeruginosa Bekhit, A.A., Fahmy, H.T.Y., Rostom, S.A.F., Baraka, A.M., 2003.
microorganisms by serial dilution method. Compound 3f has Eur. J. Med. Chem. 38, 27–36.
340 S. Malladi et al.
Benaamane, N., Nedjar-Kolli, B., Bentarzi, Y., Hammal, L., Geron- Patole, J., Shingnapurkar, D., Padhye, S., Ratledge, C., 2006. Bioorg.
ikaki, A., Eleftheriou, P., Langunin, A., 2008. Bioorg. Med. Chem. Med. Chem. Lett. 16, 1514–1517.
16, 3059–3066. Prakash, O., Pundeer, R., Ranjan, P., Pannu, K., Dhingra, Y., Aneja,
Bhandari, S.V., Bothara, K.G., Raut, M.K., Patil, A.A., Sarkate, A.P., K.R., 2009. Indian J. Chem. 48B, 563–568.
Mokale, V.J., 2008. Bioorg. Med. Chem. 16, 1822–1831. Prasad, Y.R., Lakshmana Rao, A., Prasoona, L., Murali, K., Ravi,
Gilbert, A.M., Failli, A., Shumsky, J., Yang, Y., Severin, A., Singh, K.P., 2005. Bioorg. Med. Chem. Lett. 15, 5030–5034.
G., Hu, W., Keeney, D., Petersen, P.J., Katz, A.H., 2006. J. Med. Ren, S., Wang, R., Komatsu, K., Bonaz-Krause, P., Zyrianov, Y.,
Chem. 49, 6027–6036. McKenna, C.E., Csipke, C., Tokes, Z.A., Lien, E.J., 2002. J. Med.
Hearn, M.J., Cynamon, M.H., 2004. J. Antimicrob. Chemother. 53, Chem. 45, 410–419.
185–191. Sener, A., Sener, M.K., Bildmci, I., Kasimogullari, R., Akcamur, Y.,
Holla, B.S., Veerendra, B., Shivananda, M.K., Poojary, B., 2003. Eur. 2002. J. Heterocycl. Chem. 39, 869–875.
J. Med. Chem 38, 759–767. Shi, L., Ge, H.M., Tan, S.H., Li, H.Q., Song, Y.C., Zhu, H.L., Tan,
Isloor, A.M., Kalluraya, B., Shetty, P., 2009. Eur. J. Med. Chem. 44, R.X., 2007. Eur. J. Med. Chem. 42, 558–564.
3784–3787. Sridhar, R., Perumal, P.T., Etti, S., Shanmugam, G., Ponnuswamy,
Kalsi, R., Shrimali, M., Bhalla, T.N., Barthwal, J.P., 1990. Indian J. M.N., Prabavathy, V.R., Mathivanan, N., 2004. Bioorg. Med.
Pharm. Sci. 52, 129–134. Chem. Lett. 14, 6035–6040.
Kaplan, J.P., Raizon, B.M., Desarmenien, M., Feltz, P., Headley, Sridhar, S.K., Pandeya, S.N., Stables, J.P., Ramesh, A., 2002. Eur. J.
P.M., Worms, P., Lloyd, K.G., Bartholini, G., 1980. J. Med. Chem. Pharm. Sci. 16, 129–132.
23, 702–704. Sultivan, T.J., Truglio, J.J., Boyne, M.E., Novichenok, P.,
Kucukguzel, G., Kocatepe, A., Clercq, E.D., Sahin, F., Gulluce, M., Zhang, X., Stratton, C.F., Li, H.J., Kaur, T., Amin, A.,
2006. Eur. J. Med. Chem. 41, 353–359. Johnson, F., Stayden, R.A., Kisker, C., Tonge, P.J., 2007.
Lebedev, A.V., Lebedeva, A.B., Sheludyakov, V.D., Kovaleva, E.A., ACS Chem. Biol. 1, 43–53.
Ustinova, O.L., Kozhevnikov, I.B., 2005. Russ. J. Gen. Chem. 75, Szabo, G., Fischer, J., Kis-Varga, A., Gyires, K., 2008. J. Med. Chem.
782–789. 51, 142–147.
Mackie, Cartney, Mc., 1989. Practical Medical Microbiology, 13th ed. Vijesh, A.M., Isloor, A.M., Prabhu, V., Ahmad, S., Malladi, S., 2010.
Churchill Livingstone, Edinburgh. Eur. J. Med. Chem. 45, 5460–5464.
Magedov, I.V., Manpadi, M., Slambrouck, S.V., Steelant, W.F.A., Wachter, G.A., Hartmann, R.W., Sergejew, T., Grun, G.L., Leder-
Rozhkova, E., Przheval’skii, N.M., Rogelj, S., Kornienko, A., gerber, D., 1996. J. Med. Chem. 39, 834–841.
2007. J. Med. Chem. 50, 5183–5192. Wu, J., Liu, X., Cheng, X., Cao, Y., Wang, D., Li, Z., Xu, W.,
Ozdemir, Z., Kandilici, H.B., Gumusel, B., Calis, U., Bilgin, A.A., Pannecouque, C., Witvrouw, M., De Clercq, E., 2007. Molecules
2007. Eur. J. Med. Chem. 42, 373–379. 12, 2003–2016.